InsiderFlow

Michael A Metzger

SNDX

Michael A Metzger serves as director, officer: Chief Executive Officer at Syndax Pharmaceuticals, Inc. (SNDX). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

7 trades

$3.80M

Net Position

Net Seller

$3.80M

Companies Traded

1

SNDX

Active Period

Mar 2025 – Feb 2026

7 total trades

Most Recent

Sell SNDX

Feb 10, 2026 · $360.8K

Michael A Metzger's Insider Trading at Syndax Pharmaceuticals, Inc. (SNDX)

Buys

0 · $0.00

Sells

7 · $3.80M

Total Shares Bought

0

Total Shares Sold

221,797

SNDX Price Chart
Loading chart...
DateTypeSharesAvg PriceValueShares After
Feb 10, 2026Sell17,159$21.03$360.8K491,690
Feb 9, 2026Sell17,159$21.03$360.8K0
Feb 6, 2026Sell7,412$20.62$152.8K508,849
Feb 4, 2026Sell7,412$20.62$152.8K0
Sep 8, 2025Sell157,307$16.41$2.58M0
Jul 16, 2025Sell7,534$9.29$70.0K0
Mar 4, 2025Sell7,814$15.05$117.6K0